Assessing Long-Term Safety in Systemic Lupus Erythematosus Treatment

Systemic Lupus Erythematosus Clinical Trials

Systemic Lupus Erythematosus (SLE) is a chronic autoimmune condition that can affect various organs and cause widespread inflammation. Our study is dedicated to understanding the long-term safety and effects of an investigational treatment in adults with active SLE to help improve outcomes and offer new possibilities in SLE management.

This extension study will observe participants who completed previous SLE trials, following them for up to 180 weeks. By evaluating the investigational drug’s long-term safety, its impact on disease activity, and its ability to help maintain low disease activity, we aim to uncover more effective approaches for SLE treatment.